India Diabetes Devices Market: Market Size & Forecast 2026

The India Diabetes Devices Market covers blood glucose monitors, continuous glucose monitoring systems, insulin pumps, insulin pens, and related accessories used to manage one of the world's largest diabetic populations. The market is valued at $3.89 billion in 2025 and is projected to grow steadily through the decade as healthcare access improves across both urban and rural areas. India faces a severe and worsening diabetes burden, with disease prevalence continuing to climb and projections indicating significant escalation of cases in coming decades.

• •India has the second-highest number of people living with diabetes globally, creating a large and sustained demand base
• •The market encompasses monitoring devices, insulin delivery systems, and related consumables used in both clinical and home settings
• •Diabetes care devices represent a major component of the broader $15 billion India diabetes care market that includes pharmaceuticals

The primary driver is the rising prevalence of diabetes, fueled by urbanization, sedentary lifestyles, changing dietary patterns, and genetic predisposition among the population. Technological innovations in continuous glucose monitoring and smart insulin delivery are making devices more accurate, connected, and user-friendly, expanding their appeal beyond hospital settings to home care. Increasing healthcare expenditure, greater insurance coverage, and government programs to expand diabetes screening and treatment access are further accelerating market expansion.

• •Diabetes cases are projected to rise substantially toward 101 million or more by 2045, sustaining long-term device demand
• •Advancements in continuous glucose monitoring and digital health integration are driving device upgrades and new adoption
• •Government health initiatives and growing private healthcare investment are improving access to diabetes management across socioeconomic groups

The market is broadly divided into blood glucose monitoring devices, including traditional test strips and continuous glucose monitors, and insulin delivery systems such as pens, pumps, and syringes. Glucose monitoring currently holds the largest segment share, while continuous glucose monitoring is the fastest-growing category as awareness and affordability improve. Geographically, demand is concentrated in major metropolitan areas and tier-2 cities where healthcare infrastructure is more developed, though penetration in rural regions is gradually increasing through expanded distribution networks and government health programs.

• •Blood glucose monitoring represents the dominant segment, with traditional meters still widely used alongside growing CGM adoption
• •Insulin delivery devices including pens and pumps form a substantial and expanding category driven by rising insulin dependence
• •Regional demand is strongest in western and southern India, with tier-1 and tier-2 cities leading adoption of advanced devices

What are the recent trends and outlook?

The market is moving toward connected, digital health-integrated devices with smartphone compatibility and cloud-based data management capabilities that enable remote patient monitoring and improved clinical decision-making. Domestic manufacturing initiatives and regulatory reforms are encouraging local production, which could reduce costs, improve supply chain resilience, and make devices more accessible to price-sensitive consumers. Over the forecast period, the combined effect of rising disease prevalence, affordability improvements, and new product introductions is expected to sustain the 6.1% annual growth trajectory.

• •Integration with digital health platforms and telemedicine is becoming a key differentiator as healthcare becomes more technology-driven
• •Local manufacturing and regulatory reforms aimed at boosting domestic production are expected to lower costs and improve market accessibility
• •Continuous glucose monitoring and smart insulin delivery systems are projected to be the fastest-growing categories through 2030